EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Aiming to IgE: Drug development in allergic diseases

Xiao-Jing Ling, Ji-Fu Wei, Ying Zhu

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Xiao-Jing Ling und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University…. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Asthma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 138 Literaturangaben. Gefördert von: Education Department of Jiangxi Province, Health Commission of Jiangxi Province, Gannan Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of allergic disease significantly increases in recent decades, causing it become a major public health problem all over the world. The common allergic diseases such as allergic dermatitis, allergy rhinitis, allergic asthma and food allergy are mediated, at least in part, by immunoglobulin E (IgE), and so IgE acts as a central role in allergic diseases. IgE can interact with its high-affinity receptor (FcεRⅠ) which is primarily expressed on tissue-resident mast cells and circulating basophils, initiating intracellular signal transduction and then causing the activation and degranulation of mast cells and basophils. On the other hand, IgE interaction with its low-affinity receptor (CD23), can regulate various IgE-mediated immune responses including IgE-allergen complex presentation, IgE synthesis, the growth and differentiation of both B and T cells, and the secretion of pro-inflammatory mediators. With the deeper mechanism research for allergic diseases, new therapeutic strategies for interfering IgE are developed and receive a great attention. In this review, we summarize a current profile of therapeutic strategies for interfering IgE in allergic diseases. Besides, we suggest that targeting memory B cells (including long-lived plasma cells and (or) IgE+ memory B cells) may help to completely control allergic diseases, and highlight that the development of drugs synergistically aiming to multiple targets can be a better choice for improving treatment efficacy which results from allergic diseases as the systemic disorders caused by an impaired immune system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, AllergicAsthmaHumansImmunoglobulin EBasophilsReceptors, IgEDrug DevelopmentMast Cells

Stichwörter der Autor:innen

Allergy diseasesChallengeDrug developmentIgETherapeutic strategies

Substanzen

Immunoglobulin EReceptors, IgE

Autor:innen und Institutionen

  • Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. Electronic address: weijifu@njmu.edu.cn.
  • Department of Blood Transfusion, Ganzhou Key Laboratory of Anesthesiology, Anesthesia and Surgery Center, First Affiliated Hospital of Gannan Medical University, Ganzhou, China. Electronic address: pink-shadow@gmu.edu.c…

Förderung

  • Education Department of Jiangxi Province
  • Health Commission of Jiangxi Province
  • Gannan Medical University
  • Bureau of Science and Technology of Ganzhou Municipality

Zitieren

APA

Ling, X. J., Wei, J. F., & Zhu, Y. (2023). Aiming to IgE: Drug development in allergic diseases. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110495

Vancouver

Ling XJ, Wei JF, Zhu Y. Aiming to IgE: Drug development in allergic diseases. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110495

BibTeX
@article{Ling2023,
  author = {Ling, Xiao-Jing and Wei, Ji-Fu and Zhu, Ying},
  title = {Aiming to IgE: Drug development in allergic diseases},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110495}
}
Kostenlos starten →